Teen and young women with systemic lupus erythematosus (SLE) have a higher risk of adverse pregnancy-related outcomes, including hypertensive disorders,…
Articles by Jose Marques Lopes, PhD
Top-line results of ImmuPharma’s Phase 3 clinical trial testing Lupuzor (rigerimod) as a systemic lupus erythematosus (SLE) treatment are…
Suppressing the key inflammatory protein iRhom2 reduced inflammation and prevented kidney scarring in mice susceptible to developing lupus, a study…
New York scientists have come up with a new way to measure electric signals in the major nerve running from the…
It took more than three years for 1,000 Britons with lupus, scleroderma and vasculitis to obtain a correct…
Lupus patients’ risk of an autoimmune reaction while receiving a cancer immunotherapy is no greater than the general population’s, a Mayo…
Cerebrovascular events are the fourth most frequent neuropsychiatric event in systemic lupus erythematosus (SLE) patients and mostly are due to…
The Phase 1b trial testing RA101495 as a treatment for patients with renal impairment diseases, including lupus nephritis, has dosed…
The PRKCB gene is significantly more expressed in lupus patients than in healthy controls, a new Chinese study shows. But the…
Corbus Pharmaceuticals recently started a Phase 2 clinical trial evaluating anabasum as an investigational therapy for the treatment of systemic lupus…